Leuko (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- September 23, 2022
- Vertical
- Healthcare Technology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,000,000
Company Info
- Traction
- Aims to reduce chemotherapy-related hospital readmissions by 50% and save over $6 billion annually in healthcare costs.
- Founders
- Carlos Castro-Gonzalez, Ian Butterworth, Aurelien Bourquard, Alvaro Sanchez-Ferro
- Company Description
- Leuko is a startup spun out from MIT and the Madrid M+Vision Consortium, developing a platform technology, PointCheckTM, that combines optics and AI to make noninvasive blood testing easier, faster, and more accessible than state-of-the-art solutions.
- Market
- Cancer chemotherapy patients
- Location
- Boston, MA, USA
- Coinvestors
- Good Growth Capital, HTHIAG Capital Partners, Nina Capital